Novartis AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novartis AG with three other
companies in this sector in UNITED STATES :
sales of $45.80 billion
of which 100%
was pharmaceutical products),
Merck & Co. , Inc.
Novartis AG reported sales of $49.90 billion
December of 2020.
increase of 2.6%
versus 2019, when the company's sales were $48.62 billion.
Despite this increase, sales are still
below the level achieved in 2018, when Novartis AG
reported sales of $53.17 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Novartis AG had sales
of $50.36 billion.
Sales of Innovative Medicines saw an increase
3.4% in 2020, from
$37.71 billion to $39.01 billion.
Not all segments of Novartis AG experienced an increase in sales in 2020:
sales of Sandoz fell 0.9% to $9.65 billion.